Cargando…

DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice

Maintaining DNA integrity is vital for all cells and organisms. Defective DNA repair may contribute to neurological disorders, including Alzheimer's disease (AD). We found reduced levels of BRCA1, but not of other DNA repair factors, in the brains of AD patients and human amyloid precursor prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suberbielle, Elsa, Djukic, Biljana, Evans, Mark, Kim, Daniel H., Taneja, Praveen, Wang, Xin, Finucane, Mariel, Knox, Joseph, Ho, Kaitlyn, Devidze, Nino, Masliah, Eliezer, Mucke, Lennart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674776/ https://www.ncbi.nlm.nih.gov/pubmed/26615780 http://dx.doi.org/10.1038/ncomms9897

Ejemplares similares

Physiological Brain Activity Causes DNA Double Strand Breaks in Neurons — Exacerbation by Amyloid-β
por: Suberbielle, Elsa, et al.
Publicado: (2013)

Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits
por: Harris, Julie A., et al.
Publicado: (2012)

Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture
por: Miyamoto, Takashi, et al.
Publicado: (2017)

Tau Reduction Prevents Disease in a Mouse Model of Dravet Syndrome
por: Gheyara, Ania L, et al.
Publicado: (2014)

Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice
por: Maeda, Sumihiro, et al.
Publicado: (2016)

Astrocytic adenosine receptor A(2A) and G(s)-coupled signaling regulate memory
por: Orr, Anna G., et al.
Publicado: (2015)

Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
por: Vossel, Keith A., et al.
Publicado: (2015)

Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
por: Morris, Meaghan, et al.
Publicado: (2011)

Early neuronal accumulation of DNA double strand breaks in Alzheimer’s disease
por: Shanbhag, Niraj M., et al.
Publicado: (2019)

Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer’s disease mutations but not by inhibition of BACE1
por: Johnson, Erik C. B., et al.
Publicado: (2020)

Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014)

Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity
por: Miyamoto, Takashi, et al.
Publicado: (2016)

Role of Synucleins in Alzheimer’s Disease
por: Crews, Leslie, et al.
Publicado: (2009)

APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
por: Crews, Leslie, et al.
Publicado: (2009)

Interdependence of neural network dysfunction and microglial alterations in Alzheimer’s disease-related models
por: Das, Melanie, et al.
Publicado: (2021)

Reconsideration of Alzheimer’s Disease Therapy from a Viewpoint of Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2022)

Importance of adiponectin activity in the pathogenesis of Alzheimer's disease
por: Waragai, Masaaki, et al.
Publicado: (2017)

Novel mechanisms in alcohol neurodevelopmental disorders via BRCA1 depletion and BRCA1-dependent NADPH oxidase regulation
por: Drake, Danielle M., et al.
Publicado: (2021)

VIEWPOINT FROM THE DIVISION OF NEUROSCIENCE
por: Masliah, Eliezer
Publicado: (2019)

NIA Division of Neuroscience
por: Masliah, Eliezer
Publicado: (2021)

Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
por: Waragai, Masaaki, et al.
Publicado: (2020)

Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
por: Waragai, Masaaki, et al.
Publicado: (2020)

BRCA1 tumor suppression occurs via heterochromatin mediated silencing
por: Zhu, Quan, et al.
Publicado: (2011)

Transgenerational Interaction of Alzheimer’s Disease with Schizophrenia through Amyloid Evolvability
por: Takamatsu, Yoshiki, et al.
Publicado: (2019)

Connecting Alzheimer’s Disease With Diabetes Mellitus Through Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2020)

Paradoxical delay of senescence upon depletion of BRCA2 in telomerase‐deficient worms
por: Kwon, Mi‐Sun, et al.
Publicado: (2016)

Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer’s Disease
por: Hashimoto, Makoto, et al.
Publicado: (2021)

Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers
por: Hamid, Abdulaziz B., et al.
Publicado: (2022)

Phenotypic Differences between the Alzheimer’s Disease-Related hAPP-J20 Model and Heterozygous Zbtb20 Knock-Out Mice
por: Gulbranson, Daniel R., et al.
Publicado: (2021)

The short distance contribution to the $B_{s}\rightarrow\gamma\gamma$ decay in the SM and MSSM
por: Devidze, G G
Publicado: (2000)

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
por: Evans, D G R, et al.
Publicado: (2010)

Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier
por: Chiang, Huai-Chin, et al.
Publicado: (2012)

Peptides of Presenilin-1 Bind the Amyloid Precursor Protein Ectodomain and Offer a Novel and Specific Therapeutic Approach to Reduce ß-Amyloid in Alzheimer’s Disease
por: Dewji, Nazneen N., et al.
Publicado: (2015)

BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
por: Evans, Teresa A., et al.
Publicado: (2007)

Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer’s Disease Mice
por: Leitão, André D.G., et al.
Publicado: (2023)

Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient
por: Oh, Sang Eun, et al.
Publicado: (2015)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
por: Xu, Jiqing, et al.
Publicado: (2016)

Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
por: Collins, Andrila E., et al.
Publicado: (2022)

Redox status, DNA and HSA binding study of naturally occurring naphthoquinone derivatives
por: Vukic, Milena D., et al.
Publicado: (2020)

Combined annotation‐dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancer
por: Nakagomi, Hiroshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8mg9p9qv3v5v3hb0dmmag663ee